Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study

Saved in:
Bibliographic Details
Main Authors: Marlou J. Jongkees, Susanne Bogers, Rory D. de Vries, Corine H. GeurtsvanKessel, Pedro Miranda Afonso, Kathryn S. Hensley, Bart J. A. Rijnders, Kees Brinkman, Casper Rokx, Anna H. E. Roukens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087993/?tool=EBI
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850261588724940800
author Marlou J. Jongkees
Susanne Bogers
Rory D. de Vries
Corine H. GeurtsvanKessel
Pedro Miranda Afonso
Kathryn S. Hensley
Bart J. A. Rijnders
Kees Brinkman
Casper Rokx
Anna H. E. Roukens
author_facet Marlou J. Jongkees
Susanne Bogers
Rory D. de Vries
Corine H. GeurtsvanKessel
Pedro Miranda Afonso
Kathryn S. Hensley
Bart J. A. Rijnders
Kees Brinkman
Casper Rokx
Anna H. E. Roukens
author_sort Marlou J. Jongkees
collection DOAJ
format Article
id doaj-art-67d475d283fe447795cf4052010fb299
institution OA Journals
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-67d475d283fe447795cf4052010fb2992025-08-20T01:55:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up studyMarlou J. JongkeesSusanne BogersRory D. de VriesCorine H. GeurtsvanKesselPedro Miranda AfonsoKathryn S. HensleyBart J. A. RijndersKees BrinkmanCasper RokxAnna H. E. Roukenshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087993/?tool=EBI
spellingShingle Marlou J. Jongkees
Susanne Bogers
Rory D. de Vries
Corine H. GeurtsvanKessel
Pedro Miranda Afonso
Kathryn S. Hensley
Bart J. A. Rijnders
Kees Brinkman
Casper Rokx
Anna H. E. Roukens
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
PLoS ONE
title Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
title_full Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
title_fullStr Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
title_full_unstemmed Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
title_short Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study
title_sort longitudinal assessment of covid 19 vaccine immunogenicity in people with hiv stratified by cd4 t cell count in the netherlands a two year follow up study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087993/?tool=EBI
work_keys_str_mv AT marloujjongkees longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT susannebogers longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT roryddevries longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT corinehgeurtsvankessel longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT pedromirandaafonso longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT kathrynshensley longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT bartjarijnders longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT keesbrinkman longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT casperrokx longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy
AT annaheroukens longitudinalassessmentofcovid19vaccineimmunogenicityinpeoplewithhivstratifiedbycd4tcellcountinthenetherlandsatwoyearfollowupstudy